Jul 23
SDMHF · Sartorius Stedim Biotech S.A.
$248.00
-6.56 (-2.58%)
At close · Oct 30
Return incl. dividend (before tax)
Market Cap
$24.13B
Shares
97.31M
Volume · Oct 30
1800
Avg daily vol (3M)
5012
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$248.00
Open$250.00
Day$248.00–251.00
52W close$178.30–259.65
Avg vol 30d4K
Short int51K · 0.1% of shares · 65.9d
Short vol9%
Last earningsOct 22, 2026
DataJan 2020–Oct 2026
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
0.3%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+2.5%
Trailing year
Short interest
0.1%
Latest settlement · 65.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Strong Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
High
Market backdrop
VIX 25.6 · fear
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+16%
above
Price vs 50-day avg
+15%
above
RSI (14)
62
neutral
MACD trend
Positive
52-week position
86%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+19%
trailing
6-month return
0%
trailing
YTD return
+1%
this year
Relative strength
−2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $215 › 200d $214 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.05% of shares out · ▲ +2.4% MoM · 65.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
53
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
2.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+16%
Bullish
Price vs 50-day avg
+15%
Bullish
RSI (14)
62
Neutral
MACD trend
Positive
Bullish
52-week position
86%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
Golden cross
50d $215 › 200d $214 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.05% of shares out · ▲ +2.4% MoM · 65.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $178
Now $248 · 86%
Range high $260
vs 200-day avg +16%
vs 50-day avg +15%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SDMHF
this stock
Sartorius Stedim Biotech S.A.
|
$24.13B | +0.8% | — | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$156.96B | -20.1% | +20.5% | 54.9 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$57.71B | — | +8.2% | 93.8 | 3.3% |
|
MDLN
Medline Inc.
|
$52.14B | -5.6% | +11.5% | — | 3.1% |
|
ALC
Alcon Inc
|
$36.23B | -4.9% | +10.5% | — | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SDMHF | +5.5% | +19.0% | 0.0% | +1.6% | +0.8% |
| SPY | -0.6% | -1.8% | +2.2% | -0.9% | +10.8% |
| vs SPY | +6.1% | +20.8% | -2.3% | +2.6% | -10.0% |
Capital returns
Latest dividend
$0.791
/ share · ex Mar 31, 2026
Paid (TTM)
$0.791
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.